Previous reports [54–56] have shown that the BMPR2 (bone morphogenetic protein receptor 2, a member of the TGFβR superfamily) level decreased, while its antagonist, GREM1, expression level increased, and that TGFβR was downregulated in IPF. Here, BMPR2 is linked to idiopathic pulmonary fibrosis.